Moderna Signs Vial-Filling Deal With Baxter to Bolster Supply

March 8, 2021, 3:41 PM

Moderna Inc. added a second partner in the U.S. to help fill vaccine vials, inking a deal with Baxter International Inc. to help the company produce 60 million to 90 million Covid vaccine doses in 2021.

The doses will be produced in Bloomington, Indiana by Baxter’s sterile injectable contract manufacturing unit, the companies said in a statement. “This additional production will help us continue to scale up our manufacturing capacity in the United States,” said Juan Andres, Moderna’s Chief Technical Operations and Quality Officer, in a statement.

Moderna has deals with the U.S. government to provide 300 million doses ...

To read the full article log in.

Learn more about a Bloomberg Law subscription